One-year infliximab administration for the treatment of chronic refractory pouchitis

Annals of Gastroenterology

Volumn 24, Issue 4, 2011, Pages 290-293

  Viazis, Nikos ^a   Giakoumis, Marios ^a   Koukouratos, Theodoros ^a   Saprikis, Efstathios ^a   Anastasopoulos, Elias ^a   Al Odat, Mousa ^a   Kechagias, Georgios ^a   Zacharakis, Georgios ^a   Markoglou, Konstantinos ^a   Gouma, Paraskevi ^a   Karamanolis, Demetrios G ^a  

^a EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Chronic refractory pouchitis; Ileal pouch anal anastomosis; Ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; INFLIXIMAB; MESALAZINE; PROBIOTIC AGENT;

ADULT; ANUS FISTULA; ARTHRALGIA; ARTICLE; CAPSULE ENDOSCOPY; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFICACY; ERYTHEMA NODOSUM; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; ILEITIS; ILEOANAL ANASTOMOSIS; INTESTINE FISTULA; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; REMISSION; TREATMENT DURATION; ULCERATIVE COLITIS;

EID: 81255142932     PISSN: 11087471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Melville D, Ritchie J, Nicholls R, et al. Surgery for ulcerative colitis in the era of the pouch: the St Mark's Hospital experience. Gut 1994;35:1076-1080.
2. Fazio V, Ziv Y, Church J, et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg 1995;222:120-127.
3. Biancone L, Michetti P, Travis S, et al; for the European Crohn's and Colitis Organisation (ECCO). European evidence-based Consensus on the management of ulcerative colitis: Special situations. J Crohns Colitis 2008;2:63-92.
4. Ferrante M, Declerck S, De Hertogh G, et al. Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Inflamm Bowel Dis 2008;14:20-28.
5. Sandborn W, Pardi D. Clinical management of pouchitis. Gastroenterology 2004;127:1809-1814.
6. Viscido A, Habib F, Kohn A, et al. Infliximab in refractory pouchitis complicated by fistulae, following ileo-anal pouch for ulcerative colitis. Aliment Pharamcol Ther 2003;17:1263-1271.
7. Colombel J, Ricart E, Loftus V, et al. Management of Crohn's disease of the ileoanal pouch with infliximab. Am J Gastroenterol 2003;98:2239-2244.
8. Calabrese C, Gionchetti P, Rizzello F, et al. Short term treatment with infliximab in chronic refractory pouchitis and ileitis. Aliment Pharmacol Ther 2008;27:759-764.
9. Shen B, Remzi F, Lavery I, et al. Administration of adalimumab in the treatment of Crohn's disease of the ielal pouch. Aliment Pharmacol Ther 2009;29:519-526.
10. Ferrante M, D'Haens G, Dewit O, et al. Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: A Belgian case series. Inflamm Bowel Dis 2010;16:243-249.
11. Haveran LA, Sehgal R, Poritz LS, McKenna KJ, Stewart DB, Koltun WA. Infliximab and/or azathioprine in the treatment of Crohn's disease-like complications after IPAA. Dis Colon Rectum 2011;54:15-20.
12. Acosta MB, Garcia-Bosch O, Souto R, et al. Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: a multicenter study. Inflamm Bowel Dis 2011 (in press).
13. Yeates J, Rashid M. Successful long-term use of infliximab in refractory pouchitis in an adolescent. Gastroenterol Res Pract 2010;2010:860394.
14. Molnar T, Farkas K, Nagy F, Wittmann T. Successful use of infliximab for treating fistulizing pouchitis with severe extraintestinal manifestation: a case report. Inflamm Bowel Dis 2008;14:1752-1753.